Vadadustat
AKB-6548-CI-0024
Phase 1 small_molecule completed
Quick answer
Vadadustat for Hepatic Impairment is a Phase 1 program (small_molecule) at Akebia Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Akebia Therapeutics
- Indication
- Hepatic Impairment
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed